Production (Stage)
ALX Oncology Holdings Inc.
ALXO
$0.4637
-$0.0152-3.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.46% | 5.03% | 22.06% | -10.73% | 21.75% |
| Total Depreciation and Amortization | -1.40% | 196.40% | -133.33% | 211.21% | 3.38% |
| Total Amortization of Deferred Charges | -2.90% | 4.55% | 0.00% | 3.13% | 0.00% |
| Total Other Non-Cash Items | -7.62% | -17.84% | 15.58% | -0.77% | 14.35% |
| Change in Net Operating Assets | 107.36% | -562.63% | -121.29% | 172.56% | -2,685.50% |
| Cash from Operations | 23.04% | -26.28% | 4.48% | 29.95% | 4.42% |
| Capital Expenditure | 0.00% | 59.73% | -65.56% | 39.19% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.66% | 28.64% | 2,491.98% | -96.25% | 261.16% |
| Cash from Investing | -16.69% | 29.15% | 2,732.75% | -96.57% | 258.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -303.95% | 78.77% | -64.22% | -24.57% | -177.78% |
| Issuance of Common Stock | -- | -- | -- | 13,104.22% | -99.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.62% | -98.81% | 869.67% | -229.76% | 168.73% |
| Cash from Financing | -80.18% | 30.68% | -99.08% | 779.84% | -94.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.99% | 157.92% | -61.96% | 117.85% | -396.42% |